| Post Marketing Surveillance (PMS) Study of Cresemba in Korea. (NCT04744454) | Pfizer | 2021-10-28 |
| Pharmacokinetics of Voriconazole in Adult ECMO Patients (NCT04868188) | University Hospitals, Leicester | 2021-08-10 |
| Mucormycosis in COVID-19 (NCT04935463) | Montefiore Medical Center | 2021-05-24 |
| A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus Infection (NCT04966234) | Bambino Gesù Hospital and Research Institute | 2021-04-22 |
| COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI) (NCT04818853) | University of Alabama at Birmingham | 2021-03-09 |
| THYME AND CARVACROLL Nanoparticle Effect on Fungi (NCT04431804) | Assiut University | 2020-06-11 |
| Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients (NCT05065658) | Medical University of Graz | 2020-03-01 |
| Pulmonary Aspergillosis in Tuberculosis Patients (NCT05045391) | Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan | 2020-01-01 |
| The Effect of Early Treatment of PC945 on Aspergillus Fumigatus Lung Infection in Lung Transplant Patients. (NCT03905447) | Pulmocide Ltd | 2019-09-17 |
| The Effect of PC945 on Aspergillus Fumigatus Lung Infection in Patients With Cystic Fibrosis (NCT03870841) | Pulmocide Ltd | 2019-04-03 |
| PTX3-targeted Antifungal Prophylaxis (NCT03828773) | Bochud Pierre-Yves | 2019-02-11 |
| Invasive Pulmonary Aspergillosis and Severe Influenza (NCT04232956) | University Hospital, Brest | 2018-07-27 |
| Individualisation of Voriconazole Antifungal Therapy Antifungal Therapy (NCT01887457) | Brynn Chappell | 2014-09-01 |
| Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101) (NCT02180165) | Merck Sharp & Dohme LLC | 2014-07-29 |
| Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp (NCT02646800) | Astellas Pharma China, Inc. | 2014-03-21 |
| Evaluation of Performance of An Aspergillus PCR in Tissue and Pleural Effusion Samples of Immunocompromised Patients (NCT01902030) | Heidelberg University | 2014-01-01 |
| Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects (NCT01188759) | Pfizer | 2012-05-01 |
| Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis (NCT01207128) | University of Arkansas | 2011-02-01 |
| A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074) (NCT01165320) | Merck Sharp & Dohme LLC | 2010-07-06 |
| Pre-hospital Risk Factors for Invasive Fungal Infection (NCT01315925) | Catholic University of the Sacred Heart | 2010-01-01 |
| UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer Patients (NCT01622595) | University of Arkansas | 2009-11-01 |
| An Observational Study of Fungal Biomarkers (MK-0000-089) (NCT00854607) | Merck Sharp & Dohme LLC | 2009-03-01 |
| A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects (NCT00940017) | Pfizer | 2008-09-01 |
| Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene) (NCT00620074) | Pfizer | 2008-08-01 |
| Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis (NCT00531479) | Pfizer | 2008-07-01 |
| Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi (NCT00634049) | Astellas Pharma Inc | 2008-04-22 |
| A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection (NCT00784368) | Janssen Pharmaceutical K.K. | 2008-01-01 |
| Aspergillus-specific PCR Assay in Cerebrospinal Fluid Samples for Detection of Central Nervous System Aspergillosis (NCT01617759) | Heidelberg University | 2007-09-01 |
| Evaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCT (NCT00460330) | Peking University | 2007-04-01 |
| Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis (NCT00412893) | Astellas Pharma Inc | 2007-03-07 |
| To Determine Whether Galactomannan Test Will Help to Detect Fungal Infections Early and Hence Start Treatment Early (NCT00361517) | Singapore General Hospital | 2006-06-01 |
| Surveillance of Fungal Infections During Construction Activity (NCT00473252) | Insel Gruppe AG, University Hospital Bern | 2006-05-01 |
| Voriconazole For Chronic Bronchopulmonary Aspergillosis (NCT00159822) | Pfizer | 2005-07-01 |
| Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043) (NCT00082524) | Merck Sharp & Dohme LLC | 2004-04-01 |
| Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection (NCT00388167) | PETHEMA Foundation | 2004-03-01 |
| A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections (NCT00647907) | Pfizer | 2003-04-01 |
| MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037) (NCT00076869) | Merck Sharp & Dohme LLC | 2003-01-01 |
| Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for Aspergillosis (NCT00047827) | Astellas Pharma Inc | 2002-12-01 |
| A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA). (NCT00037206) | Pfizer | 2002-05-01 |
| Voriconazole to Prevent Systemic Fungal Infections in Children (NCT00005912) | National Cancer Institute (NCI) | 2000-06-01 |
| Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis (NCT00263315) | Erasmus Medical Center | 2000-01-01 |
| Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients (NCT00001937) | National Cancer Institute (NCI) | 1999-11-01 |
| An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections (NCT00001810) | National Cancer Institute (NCI) | 1999-04-01 |
| Study of FK463 for the Treatment of Invasive Aspergillosis (NCT00036166) | Astellas Pharma Inc | 1999-01-29 |
| Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis (NCT00001646) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-08-01 |
| A Multicenter, Prospective, Randomized, Double-Blind Clinical Trial Comparing Itraconazole Oral Solution in Cyclodextrin to Placebo in the Treatment of Aspergilloma (NCT00005668) | National Institute of Allergy and Infectious Diseases (NIAID) | |